Measuring tumor-derived particles in blood samples for cancer detection
Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples
This study is testing a new, easy way to find tiny particles from tumors in small blood samples, which could help catch cancer earlier and improve treatment for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10897907 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to detect tumor-derived extracellular vesicles (EVs) in small blood samples, which can serve as biomarkers for early-stage tumors. The innovative approach eliminates the need for pre-isolation of EVs, allowing for rapid and cost-effective analysis. By using a unique assay that enhances the detection of specific EVs, the research aims to improve the accuracy of cancer diagnosis and monitoring. Patients may benefit from this minimally invasive technique that could lead to earlier detection and better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for pancreatic cancer or those with early-stage tumors.
Not a fit: Patients with advanced cancer stages or those not producing detectable levels of tumor-derived EVs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and less invasive method for early cancer detection, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using similar approaches for cancer detection, indicating potential for success in this novel method.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Hu, Tony Y. — Tulane University of Louisiana
- Study coordinator: Hu, Tony Y.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.